Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma

Figure 9

Survival analysis of PLCB3 (213384_x_at) in NSCLC. (a) Survival analysis of PLCB3 in both adenocarcinoma and squamous cell cancer. (b) Survival analysis of PLCB3 in adenocarcinoma. (c) Survival analysis of PLCB3 in squamous cell cancer. Notes: NSCLC, non-small cell lung carcinoma; PLCB3, phospholipase C beta 3; HR, hazard ratio.

(a)

(b)

(c)